675 related articles for article (PubMed ID: 23950188)
1. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
2. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular death in rheumatoid arthritis: a population-based study.
Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
Wallberg-Jonsson S; Ohman ML; Dahlqvist SR
J Rheumatol; 1997 Mar; 24(3):445-51. PubMed ID: 9058647
[TBL] [Abstract][Full Text] [Related]
5. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
6. Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
Ajeganova S; Humphreys JH; Verheul MK; van Steenbergen HW; van Nies JA; Hafström I; Svensson B; Huizinga TW; Trouw LA; Verstappen SM; van der Helm-van Mil AH
Ann Rheum Dis; 2016 Nov; 75(11):1924-1932. PubMed ID: 26757747
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.
Mackey RH; Kuller LH; Deane KD; Walitt BT; Chang YF; Holers VM; Robinson WH; Tracy RP; Hlatky MA; Eaton CB; Liu S; Freiberg MS; Talabi MB; Schelbert EB; Moreland LW
Arthritis Rheumatol; 2015 Sep; 67(9):2311-22. PubMed ID: 25988241
[TBL] [Abstract][Full Text] [Related]
8. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
9. The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis.
Öhman M; Öhman ML; Wållberg-Jonsson S
Scand J Rheumatol; 2014; 43(4):259-64. PubMed ID: 24689997
[TBL] [Abstract][Full Text] [Related]
10. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
11. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
[TBL] [Abstract][Full Text] [Related]
12. Prediction of mortality in rheumatoid arthritis based on disease activity markers.
Book C; Saxne T; Jacobsson LT
J Rheumatol; 2005 Mar; 32(3):430-4. PubMed ID: 15742433
[TBL] [Abstract][Full Text] [Related]
13. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study.
De Vera MA; Choi H; Abrahamowicz M; Kopec J; Lacaille D
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):809-16. PubMed ID: 22467274
[TBL] [Abstract][Full Text] [Related]
14. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
[TBL] [Abstract][Full Text] [Related]
15. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
16. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.
Frisell T; Holmqvist M; Källberg H; Klareskog L; Alfredsson L; Askling J
Arthritis Rheum; 2013 Nov; 65(11):2773-82. PubMed ID: 23897126
[TBL] [Abstract][Full Text] [Related]
17. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA.
Söderlin MK; Petersson IF; Bergman S; Svensson B;
Scand J Rheumatol; 2011; 40(4):249-55. PubMed ID: 21338325
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis.
Barra L; Pope JE; Orav JE; Boire G; Haraoui B; Hitchon C; Keystone EC; Thorne JC; Tin D; Bykerk VP;
J Rheumatol; 2014 Dec; 41(12):2361-9. PubMed ID: 25274884
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
20. Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.
Barra L; Bykerk V; Pope JE; Haraoui BP; Hitchon CA; Thorne JC; Keystone EC; Boire G;
J Rheumatol; 2013 Aug; 40(8):1259-67. PubMed ID: 23378461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
